(Date:7/3/2009)...ot;This is an opportunity for you to change your l...ree pills, you will experience a noticeable relief... sugar, cholesterol levels and blood pressure will...nd your mind will finally be freed from the health...tient." , Miami, FL ...
(Date:7/2/2009)...ioprocessing Technology Institute (BTI) have made ...is inhibitory molecule" (FAIM), protects both immu...ell death. , Their research is published in the... , The scientists, Jianxin Huo, Ph.D., and Sheng...y possibly be manipulated for clinical application...
(Date:7/2/2009)...re-USNewswire/ -- Pro-life forces won an important...d to uphold a state law regulating that abortion c...nistering RU-486 (also known as the "abortion pill...he drug. , , The ruling came in Rogers v. Pla...d to a 2004 law requiring that those administering...
(Date:7/2/2009)...lp reduce threat, expert says , , THURS...threat to certain species of wildlife, which need ...hers say. , "Cancer is one of the leading healt... percent of human deaths. But we now understand th... lead author Denise McAloose, chief pathologist fo...
Breaking Medicine News(10 mins):Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Cancer Endangers Some Wildlife Species 2(Date:6/29/2009)... June 29 Vantia Therapeutics, an,...small molecule drugs,targeting large, underserved...,a Phase IIa clinical trial of its lead developmen...d that oral VA106483 was successful in producing a...n patients, as determined by,increased osmolality...
(Date:6/26/2009)...6 Sanofi-aventis (EURO...re of data associated with a retrospective follow-...e data clearly show that no definitive conclusions...ship between Lantus(R) (insulin glargine [rDNA] in...s the authors of the study point out. , , Clini...
(Date:6/25/2009)...wire-USNewswire/ -- As of mid-2009, The Michael J....dy funded over $1 million in high-risk, high-rewar...t through its groundbreaking Rapid Response Innov...the safety and efficacy of an FDA-approved drug fo...ation of a tenuous link between PD and certain str...
(Date:6/24/2009)... 25 , - Recruitme...e,Non-Surgical Treatment of Eye Disease With No R...uronext Brussels: THR), a biotechnology company,f...ive treatments for eye,disease, vascular disease ...,microplasmin, which is in Phase III trials for th...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 1InVitria Reveals Technology to Optimize Hybridoma Production Performance 43244 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 1Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 2Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 3Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 4Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 5Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 6Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 7Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 8Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 9Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 10Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 11Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 12Lotus Pharmaceuticals Inc Reports Strong 2008 Financial Results 43243 13New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 1New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 2New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 3New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 43241 4University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 1University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 2University of Texas at Austin engineer elected to American Academy of Arts and Sciences 8122 3... Potent Synergy, Activity and Patient Tolerance Su...ry Therapy, BARCELONA, Spain, April 12, 2007 /PRNe...y held biopharmaceutical company,today announced ...eron with or without ribavirin in treatment-naive ...results demonstrate that,omega interferon in combi...
... SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRI...biopharmaceutical company focused,on advancing can...ta(tm) (talotrexin) for Injection at the American ...ng April 14-18, 2007 in Los,Angeles, California. ,... with,paclitaxel in A549 non-small cell lung cance...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3Disposable Microscissors: Horizontal Curved Microscissors
Sharp tipped illuminated scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and
Disposable Microscissors: Vertical, 90
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose
Medicine Products: